Childhood cancer in the United States now has a five-year survival rate of 80 percent. Thanks to improved methods of treatment, most pediatric patients grow up to lead active lives.
Surgical oncologist Monica Morrow is an internationally renowned expert in breast cancer with more than 20 years of experience leading research, education, and treatment programs.
Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan-Kettering Institute, has been named the recipient of two prestigious awards.
According to Memorial Sloan-Kettering researchers, circulating tumor cell counts could help physicians in making treatment decisions and facilitate clinical studies.
Memorial Sloan-Kettering medical oncologist Katharine C. Hsu and colleagues have described an immune benefit of allogeneic, or donor-provided, blood stem cell transplants in patients being treated for leukemia.
Memorial Sloan-Kettering has announced the creation of the Louis V. Gerstner, Jr. Young Investigators Fund and has named the fund's first four recipients.
On January 29, Memorial Sloan-Kettering hosted a screening of Naturally Obsessed: The Making of a Scientist, produced and directed by Sloan-Kettering Institute Chairman Emeritus Richard A. Rifkind and his wife, Carole.
Memorial Sloan-Kettering has now made keeping track of details regarding care easier by creating a private, personalized online link for patients to access this information and communicate with their physicians and nurses.
Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research.
James A. Eastham has been named Chief of the Urology Service in the Department of Surgery and the incumbent of the Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology.